Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
Allurion Technologies (NYSE: ALUR) has announced it will report its third quarter 2024 financial results on November 13, 2024. The company will host a conference call at 8:30 AM ET on the same day to discuss financial results and provide a business update. Investors can access the call via telephone at (888) 330-3417 (domestic) or +1 646 960 0804 (international) using Conference ID 1905455. A live audio webcast will be available on Allurion's Investor Relations website, with replay options available afterward.
Allurion Technologies (NYSE: ALUR) ha annunciato cherenderà noti i suoi risultati finanziari del terzo trimestre 2024 il 13 novembre 2024. L'azienda ospiterà una conferenza telefonica alle 8:30 AM ET dello stesso giorno per discutere i risultati finanziari e fornire un aggiornamento sull'attività. Gli investitori possono accedere alla chiamata tramite telefono al numero (888) 330-3417 (nazionale) o al +1 646 960 0804 (internazionale) utilizzando l'ID Conferenza 1905455. Sarà disponibile un webcast audio dal vivo sul sito delle Relazioni con gli Investitori di Allurion, con opzioni di registrazione disponibili in seguito.
Allurion Technologies (NYSE: ALUR) ha anunciado que informará sobre sus resultados financieros del tercer trimestre de 2024 el 13 de noviembre de 2024. La compañía llevará a cabo una conferencia telefónica a las 8:30 AM ET el mismo día para discutir los resultados financieros y proporcionar una actualización empresarial. Los inversores pueden acceder a la llamada por teléfono al (888) 330-3417 (nacional) o al +1 646 960 0804 (internacional) utilizando el ID de Conferencia 1905455. Un webcast de audio en vivo estará disponible en el sitio web de Relaciones con Inversores de Allurion, con opciones de repetición disponibles después.
Allurion Technologies (NYSE: ALUR)가 2024년 11월 13일 2024년 3분기 재무 결과를 보고할 것이라고 발표했습니다. 회사는 같은 날 오전 8:30 ET에 재무 결과를 논의하고 사업 업데이트를 제공하기 위해 컨퍼런스 콜을 개최합니다. 투자자들은 (888) 330-3417 (국내) 또는 +1 646 960 0804 (국제)로 전화를 통해 회의 ID 1905455를 사용하여 통화에 참여할 수 있습니다. Allurion의 투자자 관계 웹사이트에서 생중계 오디오 웹캐스트가 제공되며, 이후 재생 옵션도 이용 가능합니다.
Allurion Technologies (NYSE: ALUR) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le 13 novembre 2024. La société organisera une conférence téléphonique à 8h30 ET le même jour pour discuter des résultats financiers et fournir une mise à jour commerciale. Les investisseurs peuvent accéder à l'appel par téléphone au (888) 330-3417 (national) ou au +1 646 960 0804 (international) en utilisant l'ID de conférence 1905455. Un webinaire audio en direct sera disponible sur le site des relations investisseurs d'Allurion, avec des options de rediffusion disponibles par la suite.
Allurion Technologies (NYSE: ALUR) hat angekündigt, dass es am 13. November 2024 seine finanziellen Ergebnisse des dritten Quartals 2024 bekannt geben wird. Das Unternehmen wird am selben Tag um 8:30 AM ET eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse zu besprechen und ein Update zum Geschäft zu geben. Investoren können an dem Gespräch über das Telefon unter (888) 330-3417 (national) oder +1 646 960 0804 (international) mit der Konferenz-ID 1905455 teilnehmen. Ein Live-Audio-Webcast wird auf der Investor-Relations-Website von Allurion verfügbar sein, danach stehen auch Wiederholungsoptionen zur Verfügung.
- None.
- None.
To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (international) and use Conference ID 1905455. To listen to the conference call via live audio webcast, please visit the Events section of Allurion’s Investor Relations website at Allurion - Events & Presentations.
A replay of the conference call will be available by telephone by dialing (800) 770 2030 and using Access Code 1905455. The archived webcast will also be available on Allurion’s Investor Relations website mentioned above.
About Allurion
Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, Procedure-less™ intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Coach Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in
For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.
Allurion is a trademark of Allurion Technologies, Inc. in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030052745/en/
Global Media
Cedric Damour
PR Manager
+33 7 84 21 02 20
cdamour@allurion.com
Investor Contact
Mike Cavanaugh, Investor Relations
ICR Westwicke
(617) 877-9641
mike.cavanaugh@westwicke.com
Source: Allurion Technologies, Inc.
FAQ
When will Allurion (ALUR) release Q3 2024 earnings?
What time is Allurion's (ALUR) Q3 2024 earnings call?
How can I access Allurion's (ALUR) Q3 2024 earnings call?
